Abstract A deficiency of α-galactosidase A causes Fabry disease (FD) by disrupting lipid metabolism, especially trihexosylceramide (THC). Enzyme replacement therapy (ERT) is clinically offered to FD patients in an attempt to lower the accumulated lipids. Studies on specific types of lipids that are directly or indirectly altered by FD are very scarce, even though they are crucial in understanding the biological process linked to the pathogenesis of FD. We performed a comprehensive lipid profiling of plasma and urinary lipids from FD patients with nanoflow liquid chromatography electrospray-ionization tandem mass spectrometry (nLC-ESI-MS/MS) and identified 129 plasma and 111 urinary lipids. Among these, lipids that exhibited alternations (>twofold) in patients were selected as targets for selected reaction monitoring (SRM)-based high-speed quantitation using nanoflow ultra-performance LC-ESI-MS/MS (nUPLC-ESI-MS/MS) and 31 plasma and 26 urinary lipids showed significant elevation among FD patients. Higher percentages of sphingolipids (SLs; 48 �or plasma and 42 �or urine) were highly elevated in patients; whereas, a smaller percentage of phospholipids (PLs; 15 �or plasma and 13 �or urine) were significantly affected. Even though α-galactosidase A is reported to affect THC only, the results show that other classes of lipids (especially SLs) are changed as well, indicating that FD not only alters metabolism of THC but various classes of lipids too. Most lipids showing significant increases in relative amounts before ERT decreased after ERT, but overall, ERT influenced plasma lipids more than urinary lipids. Graphical abstractBrief overview of lipidomic analysis for Fabry disease using nLC-ESI-MS/MS and nUPLC-ESI-MS/MS.
plasma              0.9999995179290434^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Blood_plasma          

urine                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Urine                 

lipid                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

plasma                        0.9999995179290434^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Blood_plasma          

Enzyme replacement therapy    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Enzyme_replacement_therapy

ERT                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Enzyme_replacement_therapy

pathogenesis                  0.999998678910933^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Pathogenesis          

lipids                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

lipids                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

FD                            0.7884188536408848^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Canon_FD_lens_mount   

plasma                        0.9999995179290434^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Blood_plasma          

urinary                       0.9999999999979536^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Urine                 

lipids                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

lipids                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

alternations                  0.8680948931953528^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Apophony              

FD                            0.7884188536408848^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Canon_FD_lens_mount   

FD                            0.7884188536408848^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Canon_FD_lens_mount   

MS                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Multiple_sclerosis    

liquid chromatography         0.9999999308440717^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/High-performance_liquid_chromatography

SRM                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Selected_reaction_monitoring

biological process            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Biological_process    

ERT                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Enzyme_replacement_therapy

Fabry disease                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Fabry_disease         

lipids                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

THC                           0.9999912902566889^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Tetrahydrocannabinol  

MS                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Multiple_sclerosis    

lipid metabolism              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

sphingolipids                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Sphingolipid          

FD                            0.7884188536408848^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Canon_FD_lens_mount   

plasma                        0.9999995179290434^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Blood_plasma          

FD                            0.7884188536408848^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Canon_FD_lens_mount   

tandem mass spectrometry      0.9998230678610307^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mass_spectrometry     

FD                            0.7884188536408848^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Canon_FD_lens_mount   

SLs                           0.9999850954187673^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mercedes-Benz_SL-Class

plasma                        0.9999995179290434^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Blood_plasma          

ERT                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Enzyme_replacement_therapy

lipids                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

α-galactosidase               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Alpha-galactosidase   

α-galactosidase               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Alpha-galactosidase   

urinary                       0.9999999999979536^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Urine                 

lipids                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

urinary                       0.9999999999979536^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Urine                 

urine                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Urine                 

elevation                     0.9077373012269784^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Angle_of_incidence    

lipids                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

plasma                        0.9999995179290434^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Blood_plasma          

lipids                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

MS                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Multiple_sclerosis    

lipids                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

THC                           0.9999912902566889^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Tetrahydrocannabinol  

phospholipids                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Phospholipid          

FD                            0.7884188536408848^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Canon_FD_lens_mount   

selected reaction monitoring  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Selected_reaction_monitoring

urinary                       0.9999999999979536^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Urine                 

quantitation                  0.9999953753251776^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Detection_limit       

THC                           0.9999912902566889^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Tetrahydrocannabinol  

MS                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Multiple_sclerosis    

metabolism                    0.9999999996925908^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Metabolism            

ERT                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Enzyme_replacement_therapy

lipids                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

SLs                           0.9999850954187673^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mercedes-Benz_SL-Class

MS                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Multiple_sclerosis    

Fabry disease                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Fabry_disease         

